Comparison of Jacobson Relaxation Technique and Pranayama Technique in Patients With COPD
1 other identifier
interventional
30
1 country
1
Brief Summary
Comparison of Jacobson Relaxation Technique and Pranayama Technique in patients with COPD
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Jul 2023
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
July 20, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
December 10, 2023
CompletedFirst Submitted
Initial submission to the registry
March 4, 2024
CompletedFirst Posted
Study publicly available on registry
June 17, 2024
CompletedJune 17, 2024
June 1, 2024
4 months
March 4, 2024
June 12, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (3)
Dyspnea Severity (Borg Scale)
The Borg scale measures the severity of dyspnea (shortness of breath). Scale Details: Full Title: Borg Rating of Perceived Exertion (RPE) ScaleFull Title: Borg Rating of Perceived Exertion (RPE) Scale Minimum Value: 0 (No breathlessness at all) Maximum Value: 10 (Maximal breathlessness) Interpretation: Higher scores indicate worse outcomes, meaning greater severity of dyspnea.
4 weeks
Cough and Sputum Analysis (CASA-Q)
The CASA-Q (Cough and Sputum Assessment Questionnaire) evaluates the severity and impact of cough and sputum production. Scale Details: Full Title: Cough and Sputum Assessment Questionnaire (CASA-Q) Minimum Value: 0 (No symptoms) Maximum Value: 100 (Severe symptoms) Interpretation: Higher scores indicate worse outcomes, meaning more severe symptoms of cough and sputum.
4 Weeks
Spirometry (FEV1 and FVC)
Spirometry will be used to measure lung function, specifically Forced Expiratory Volume in 1 second (FEV1) and Forced Vital Capacity (FVC). Scale Details: Full Title: Spirometry (FEV1 and FVC) Minimum Value: Variable (dependent on patient's lung function) Maximum Value: Variable (dependent on patient's lung function) Interpretation: Higher values typically indicate better lung function.
4 Weeks
Secondary Outcomes (2)
Quality of Life (SF-36 Questionnaire)
4 Weeks
Patient Satisfaction (Patient Satisfaction Questionnaire)
4 Weeks
Study Arms (2)
Jacobson's Technique
EXPERIMENTALParticipant in the group A were instructed to perform the Jacobson relaxation technique. * Quite place were chosen where there is no disturbance. * Patients were relax either on the lying position or sitting position with head well-supported. * Patients were instructed to loosen any tight clothing. * Patients were educated for muscles of each group emphasis on attention on that muscle group only. * Repeat this three times, constrict the muscle and then relax, tens the muscle and maintain it for five seconds then relax it lightly and then tense and relax. Constrict the muscle very slightly then relax it. Focus on each muscle group and then decide to relax the target muscle.
Pranayama Technique
ACTIVE COMPARATORParticipant in group B were instructed to perform the pranayama relaxation technique. * Quite place were chosen where there is no disturbance and patient were relaxed in sitting position with spine straight. * In this technique patients were instructed to perform different type of pranayama techniques. * Guide the participants to take a steady breath in through your both nostrils. Then inhale until you reach your total lung capacity, maintaining a tall spine. Treatment was continuous 4 weeks, 3 times in a week for 15 mint. Assessment was done through the tool before and after the treatment.
Interventions
Quality of life, cough and sputum analysis, spirometry, and shortness of breath were assessed.
Quality of life, cough and sputum analysis, spirometry, and shortness of breath were assessed.
Eligibility Criteria
You may qualify if:
- Patients of Age between 40 and 70.
- Both Genders (Male, Female) were included.
- Stage 2 patient with COPD with Dyspnea FEV1 \<70% and Maximal Expiratory Pressure = 50% (Gold Criteria) were included.
- Cognitive Stable patients were included.
- Those Patients were included who were clinically stable without exacerbations in the past 01 month.
You may not qualify if:
- Common Cough
- Upper respiratory tract inflammation
- Patients who have other co-morbid diseases which prevents them from exercise training, for example, disability due to neurological, orthopedic and acute cardiac causes
- Patients who were mentally and physically and sick to join at the hospital or research site for training
- Patients who were already participated or completed or in a P.R program in the past one year.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Gulab Devi Chest Hospital
Lahore, Punjab Province, 54000, Pakistan
Related Publications (5)
Pauwels RA, Buist AS, Ma P, Jenkins CR, Hurd SS; GOLD Scientific Committee. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: National Heart, Lung, and Blood Institute and World Health Organization Global Initiative for Chronic Obstructive Lung Disease (GOLD): executive summary. Respir Care. 2001 Aug;46(8):798-825. No abstract available.
PMID: 11463370BACKGROUNDPetty TL. The history of COPD. Int J Chron Obstruct Pulmon Dis. 2006;1(1):3-14. doi: 10.2147/copd.2006.1.1.3.
PMID: 18046898BACKGROUNDOzgundondu B, Gok Metin Z. Effects of progressive muscle relaxation combined with music on stress, fatigue, and coping styles among intensive care nurses. Intensive Crit Care Nurs. 2019 Oct;54:54-63. doi: 10.1016/j.iccn.2019.07.007. Epub 2019 Jul 29.
PMID: 31371164BACKGROUNDRanjita R, Hankey A, Nagendra HR, Mohanty S. Yoga-based pulmonary rehabilitation for the management of dyspnea in coal miners with chronic obstructive pulmonary disease: A randomized controlled trial. J Ayurveda Integr Med. 2016 Jul-Sep;7(3):158-166. doi: 10.1016/j.jaim.2015.12.001. Epub 2016 Aug 18.
PMID: 27545747BACKGROUNDBasoglu OK, Atasever A, Bacakoglu F. The efficacy of incentive spirometry in patients with COPD. Respirology. 2005 Jun;10(3):349-53. doi: 10.1111/j.1440-1843.2005.00716.x.
PMID: 15955148BACKGROUND
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Sumera Hameed, MS
Riphah International University
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- PARTICIPANT
- Masking Details
- Single
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
March 4, 2024
First Posted
June 17, 2024
Study Start
July 20, 2023
Primary Completion
December 1, 2023
Study Completion
December 10, 2023
Last Updated
June 17, 2024
Record last verified: 2024-06
Data Sharing
- IPD Sharing
- Will not share